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Real-world effectiveness of influenza vaccination 
in older adults in the UK from 1997-2012: a quasi-experimental 
cohort study 
 
Background 
 
Ageing is associated with a decline in the normal function of the immune system which may 
limit the effectiveness of the influenza vaccine. However, the absence of strong evidence 
from randomised controlled trials and conflicting results from observational studies has led 
to ongoing debate about the effectiveness of influenza vaccination in the elderly.  
 
Objectives 
 
To determine the real world effectiveness of the influenza vaccine in UK adults aged 65y and 
older, and its relationship with age and receipt of the pneumococcal vaccination. 
 
Method 
 
Design 
 
Quasi-experimental cohort study of patients in the UK from general practices registered to 
the Clinical Practice Research Datalink with linkage to Hospital Episode Statistics and the 
Office of National Statistics databases. 
 
Setting 
 
Adults aged 65y and over, recruited, starting in September, in annual cohorts from 1997 to 
2012, with no record of influenza vaccination in the preceding five years.  
 
Exposure 
 
Influenza vaccination 
  
Outcome measure 
 
Hospitalisation for influenza, and prescriptions for antibiotics for symptoms consistent with 
lower respiratory tract infections. 
 
Statistical analysis 
 
Application of the pairwise Prior Event Rate Ratio (PERR) method to estimate vaccine 
effectiveness in each annual cohort after removing the effect of time-invariant unmeasured 
confounding using outcomes from the year before vaccination. Vaccination effectiveness 
was also studied by age and pneumococcal (PPV) vaccination subgroups. 
 
Results 
The rates of influenza in the year before vaccination were higher for patients that 
proceeded to be vaccinated than for patients who remained unvaccinated, indicating the 
presence of confounding bias. Adjustment for this bias using the pairwise PERR method, 
showed that influenza vaccination was moderately effective in all cohorts (HR ranging from 
0.59 in 2012 to 0.89 in 2001, all significant at the 5% level except 2001). There was no 
discernible difference in influenza effectiveness between the PPV subgroups, although 
accuracy was affected by fewer patients in the PPV group. There was also no significant age 
interaction except for the 2009 cohort, for which effectiveness of vaccination increased with 
age. 
 
Conclusions 
 
The UK policy of vaccinating older adults is effective at reducing risk of influenza infection. 
There was no clear evidence to suggest influenza vaccine effectiveness was attenuated by 
the pneumococcal vaccine and no consistent moderation of effectiveness with increasing 
age. 
 
 
